Germany
Japan
United Kingdom
China
UltraMAB®, the Ultra Specific Antibody
Validated against > 10,000 human antigens
Some commonly used diagnostic antibodies perform well in applications but cross-react with other unrelated proteins. This cross-reactivity may potentially cause unexpected side effects and generate false diagnostic reports. OriGene is proud to announce the development of High-Density Protein Microarray for antibody specificity testing. View details of High-Density Protein Microarray
Using this microarray spotted with 17,000 different over-expressed proteins, we have validated the specificity of existing HER2 (view case studies) and ERCC1 diagnostic antibody (View publication on the validation of ERCC1 antibodies). This protein microarray technology has also been applied to identify UltraMAB®, the ultra-specific antibodies for cancer biomarkers and other important diagnostic targets. Major applications of validated UltraMAB® include Western blot, IHC, IF, ICC, and FACS.
- Mono-specificity test
- WB with cell lines and tissue lysates
- IHC staining with over 25 types of normal and cancer human tissues
- IF/ICC
- FACS
» Search Your UltraMAB® Antibody (browse all)
Browse by target
ABAT
AGR2
ALDH1L1
ALX4
AMACR
BBOX1
BCL2
BID
BMP4
CD38
CD3E
CD4
CD40
CD44
CD5
CD68
CD74
CD80
CD8A
CD99
CDX2
CRABP2
CTLA4
DDX56
DEF6
DOCK2
EGFR
EPCAM
ERCC1
ERG
EZH2
FGF21
FOXP1
FOXP3
FTCD
GATA3
GBA
GFAP
GLI1
HAO1
HEMGN
HMBS
IDO1
IRF6
L1CAM
LGR5
MADCAM1
MCM2
MEF2C
MET
MGMT
MLH1
MMP7
MRPS34
MRPS7
MSH2
MSI1
MSMB
PARN
PBX1
PCNA
PDSS2
PROCR
RRM1
S100A9
S100P
SDHB
SERPINB4
SOX5
SQSTM1
TNFRSF18
TP63
WIBG
XRCC1